ALX3 is a paired-class homeodomain transcription factor that functions as a developmental regulator with context-specific roles in craniofacial and pancreatic development 1. As a sequence-specific DNA-binding transcription factor, ALX3 exhibits selective monomeric and dimeric binding modes depending on target site sequences and cellular context, with transactivation requiring proline-rich domains amino-terminal to its homeodomain 2. Its promoter activity is differentially regulated by Twist1, USF1, and USF2 in mesenchymal versus pancreatic cells, reflecting tissue-specific transcriptional control 3. During development, ALX3 plays critical roles in anterior cranial neural crest (aCNC) migration and craniofacial morphogenesis; loss-of-function mutations in ALX1/ALX3 cause frontonasal dysplasia with ocular anterior segment malformations and aberrant hyaloid vasculature 4. ALX3 also participates in hair follicle niche regulation through Hedgehog signaling-activated transcriptional networks that control mesenchymal-epithelial interactions 5. Clinically, ALX3 promoter hypermethylation occurs in neuroblastoma and lung cancer, with methylation serving as a potential biomarker; methylation correlates with gene silencing in neuroblastoma but paradoxically associates with elevated expression in lung adenocarcinomas 67. These findings establish ALX3 as a conserved developmental regulator with tumor-associated epigenetic alterations.